Ovation Science Inc. (CSE:OVAT)
0.0400
0.00 (0.00%)
Dec 4, 2025, 3:32 PM EST
Ovation Science Revenue
Ovation Science had revenue of 13.56K CAD in the quarter ending September 30, 2025, a decrease of -6.17%. This brings the company's revenue in the last twelve months to 63.82K, down -42.99% year-over-year. In the year 2024, Ovation Science had annual revenue of 113.22K with 82.80% growth.
Revenue (ttm)
63.82K
Revenue Growth
-42.99%
P/S Ratio
24.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113.22K | 51.28K | 82.80% |
| Dec 31, 2023 | 61.93K | -76.22K | -55.17% |
| Dec 31, 2022 | 138.15K | -86.80K | -38.58% |
| Dec 31, 2021 | 224.95K | -525.06K | -70.01% |
| Dec 31, 2020 | 750.01K | 447.63K | 148.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |